1. covid19criticalcare.com
2. upregulaters ROS production
2.1. Main cause of patholoy
3. Has heart issues in many patients
3.1. glutathione
4. Dose by Weight
4.1. Dose once weekly
5. Binds to ACE Receptor
6. CoQ10
7. Singapore
8. Dr Horowitz
8.1. No clinical trials
8.2. Causes Von Willebrand factor to increase causing capillary clotting
8.3. Case Study Pubmed
8.3.1. Remdesivir
9. Vitamin E
10. UV blood irradiation
10.1. Works in the early viral reproduction stage
11. AT 1,7 Decreased
12. Pro-Inflammatory AT II Increased
12.1. Damage to membranes
13. Hyrdoxychloroquine
14. Lipoic Acid 500 mg
15. MAH major autohemotherapy
16. Video Discussion
17. inhaler not effective
18. induces inflammatory cytokines
19. Case Studies done
20. Controlled by Antioxidant System
20.1. NAC
21. Vitamin C
22. Ivermectin
22.1. Multiple Studies
23. UV blood irradiation
24. Reduce Viral replication
25. Pulmicort (Budesimide)
25.1. Nebulized
25.2. Infection clears in 19 days
26. Asymptomatic is Anti-oxidant system capable of controlling ROS
27. Pathology
27.1. Damage to capillaries
27.2. ROS Superoxide
27.2.1. Oxidative Therapy
27.2.1.1. Ozone
27.2.1.2. Successful in Spain
27.2.2. Glutathione
27.2.2.1. Converts superoxide to water
27.2.2.2. Can be reset
27.2.2.2.1. Lipoid acid
27.2.2.2.2. Other antioxidants
27.2.2.3. Low values associated with severity
27.2.2.4. We will
27.2.3. Lipoic Acid
27.2.3.1. Reduces glutathione
27.2.3.2. Number one deficiency
28. Treatment
28.1. Reduce Oxidative Stress
28.1.1. Works Rapidly within 24 hours
28.1.1.1. Glutathione
28.1.1.2. Hydrogen Peroxide IV
28.1.1.2.1. Using in flu pandemic of 1918
28.1.1.3. Agents
28.1.1.3.1. Lipoic Acid
28.1.1.4. NAC
28.1.1.5. IV therapy
28.1.1.5.1. Vitamin C
28.1.1.5.2. thousands of peer reviewed studies done
28.1.1.5.3. Safe
28.1.1.5.4. Our IV Protocol
28.1.1.5.5. Used early
28.1.2. Symptomatic if ROS exceeds anti-oxidant capacitiy
28.2. Inhaler therapy
28.2.1. Agents
28.2.1.1. lipoic acid
28.2.1.2. Japan
28.2.2. Successful
28.2.2.1. Taiwan